Publications by authors named "Stephen Poor"

Claim this Profile
P
Patient-reported vision impairment in low luminance relates to visual function in age-related macular degeneration: A MACUSTAR study report.
Jan Henrik Terheyden, Charlotte Behning, Hannah M P Dunbar, Stephen Poor, Nadia Zakaria

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Spectrum of Functional, Structural, and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration: A MACUSTAR Study Report.
Jan Henrik Terheyden, Frank G Holz, Charlotte Behning, Hannah M P Dunbar, Steffen Schmitz-Valckenberg, Stephen Poor

Ophthalmologica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous Visual Function Deficits in Intermediate Age-Related Macular Degeneration: A MACUSTAR Report.
Hannah M P Dunbar, David P Crabb, Charlotte Behning, Alison M Binns, Amina Abdirahman, Stephen Poor

Ophthalmol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study report.
Jan Henrik Terheyden, Susanne G Pondorfer, Charlotte Behning, Moritz Berger, Jill Carlton, Stephen Poor

Br J Ophthalmol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Test-Retest Variability and Discriminatory Power of Measurements From Microperimetry and Dark Adaptation Assessment in People With Intermediate Age-Related Macular Degeneration - A MACUSTAR Study Report.
Bethany E Higgins, Giovanni Montesano, Hannah M P Dunbar, Alison M Binns, Deanna J Taylor, Stephen Poor

Transl Vis Sci Technol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Spatial Distribution of Structural Features in Age-Related Macular Degeneration: A MACUSTAR Study Report.
Marlene Saßmannshausen, Charlotte Behning, Jonas Weinz, Lukas Goerdt, Jan H Terheyden, Stephen H Poor

Ophthalmol Retina· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report.
Davide Garzone, Jan Henrik Terheyden, Olivier Morelle, Maximilian W M Wintergerst, Marlene Saßmannshausen, Stephen Poor

Sci Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement factor B is critical for sub-RPE deposit accumulation in a model of Doyne honeycomb retinal dystrophy with features of age-related macular degeneration.
Maura A Crowley, Donita L Garland, Holger Sellner, Angela Banks, Lin Fan, Stephen Poor

Hum Mol Genet· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report.
Davide Garzone, Jan Henrik Terheyden, Olivier Morelle, Maximilian W M Wintergerst, Marlene Saßmannshausen, Stephen Poor

Sci Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study Report.
Hannah M P Dunbar, Charlotte Behning, Amina Abdirahman, Bethany E Higgins, Alison M Binns, Stephen Poor

JAMA Ophthalmol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration.
Stephen H Poor, Georges Weissgerber, Christopher M Adams, Harit Bhatt, David J Browning

Am J Ophthalmol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials.
Antonio Yaghy, Aaron Y Lee, Pearse A Keane, Tiarnan D L Keenan, Luisa S M Mendonca, Stephen Poor

Exp Eye Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proteogenomic signature of age-related macular degeneration in blood.
Valur Emilsson, Elias F Gudmundsson, Thorarinn Jonmundsson, Brynjolfur G Jonsson, Michael Twarog, Stephen Poor

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration.
John T Demirs, Junzheng Yang, Maura A Crowley, Michael Twarog, Omar Delgado, Stephen Poor

Invest Ophthalmol Vis Sci· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening Medications for Association with Progression to Wet Age-Related Macular Degeneration.
Shirley V Wang, Martin Kulldorff, Stephen Poor, Dennis S Rice, Angela Banks

Ophthalmology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV).
Adrian Will-Orrego, Yubin Qiu, Elizabeth S Fassbender, Siyuan Shen, Jorge Aranda, Stephen H Poor

J Ocul Pharmacol Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.
Christopher M Adams, Karen Anderson, Gerald Artman, Jean-Claude Bizec, Rosemarie Cepeda, Stephen Poor

J Med Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting protein drugs for the treatment of ocular diseases.
Joy G Ghosh, Andrew A Nguyen, Chad E Bigelow, Stephen Poor, Yubin Qiu

Nat Commun· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Core Replacements in a Potent Series of VEGFR-2 Inhibitors and Their Impact on Potency, Solubility, and hERG.
Nello Mainolfi, James Powers, Erik Meredith, Jason Elliott, Karl G Gunderson, Stephen Poor

ACS Med Chem Lett· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of involvement of CEP adducts in TLR activation and in angiogenesis.
John Gounarides, Jennifer S Cobb, Jing Zhou, Frank Cook, Xuemei Yang, Stephen Poor

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration.
Erik L Meredith, Nello Mainolfi, Stephen Poor, Yubin Qiu, Karl Miranda

J Med Chem· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation.
Stephen H Poor, Yubin Qiu, Elizabeth S Fassbender, Siyuan Shen, Amber Woolfenden

Invest Ophthalmol Vis Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk segmentation related to the offering of a consumer-directed health plan: a case study of Humana Inc.
Laura A Tollen, Murray N Ross, Stephen Poor

Health Serv Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis